OA16.02 The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer

D. Ezeife,E. Spackman,R. Juergens,J. Laskin,J. Agulnik,D. Hao,S. Laurie,J. Law,L. Le,L. Kiedrowski,B. Melosky, F.A. Shepherd,V. Cohen, P. Wheatley-Price,R. Vandermeer,J. Li,R. Fernandes,A. Shokoohi, R. Lanman,N. Leighl

Journal of Thoracic Oncology（2021）

引用 6|浏览11

暂无评分

摘要

The addition of LB to TT as initial molecular testing of clinically selected patients with advanced NSCLC did not increase system costs and led to more patients receiving appropriate targeted therapy.

查看译文

关键词

Liquid biopsy, Economics, NSCLC

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要